Among people who planned to quit, 93% had experienced side effects, but only 36% were still losing weight, suggesting that lack of results, not discomfort, drove discontinuation
PRESENTATION Clinically, four phases of the illness can be recognised: A prodromal phase with a feeling that an episode is about to start, followed by intense sweating and nausea with or without abdominal pain, and a pale appearance
The missed-pill rule (which applies to every GLP-1) Nausea is the most common side effect across the entire GLP-1 class about 1 in 3 patients on Wegovy report it, and rates are higher during the first few weeks and after dose increases
A broader perspective on tirzepatide in the context of other weight management peptides is available through our peptides for fat loss overview and our ranking of the best peptides for weight loss
Your doctors consider your individual risk factors, existing eye health, and overall medical needs when selecting which medication is most appropriate
J.GauntP.AithalG